The DOI matches its Crossref record, with a small difference in title or year; 37 of the 38 references it cites were found in a registry or an index.
Increasing Cardiovascular Disease Burden Due to Diabetes Mellitus: The Framingham Heart Study
Abstract
Background— Marked reductions in cardiovascular disease (CVD) morbidity and mortality have occurred in the United States over the last 50 years. We tested the hypothesis that the relative burden of CVD attributable to diabetes mellitus (DM) has increased over the past 5 decades. Methods and Results— Participants aged 45 to 64 years from the Framingham Heart Study, who attended examinations in an “early” time period (1952 to 1974), were compared with those who attended examinations in a later time period (1975 to 1998). The risk of CVD events (n=133 among those with and 1093 among those without DM) attributable to DM in the 2 time periods was assessed with Cox proportional hazards models; population attributable risk of DM as a CVD risk factor was calculated for each time period. The age- and sex-adjusted hazard ratio for DM as a CVD risk factor was 3.0 (95% CI, 2.3 to 3.9) in the earlier time period and 2.5 (95% CI, 1.9 to 3.2) in the later time period. The population attributable risk for DM as a CVD risk factor increased from 5.4% (95% CI, 3.8% to 6.9%) in the earlier time period to 8.7% (95% CI, 5.9% to 11.4%) in the later time period ( P for attributable risk ratio=0.04), although multivariable adjustment resulted in attenuation of these findings ( P =0.12); most of these observations were found among men. Conclusions— The proportion of CVD attributable to DM has increased over the past 50 years in Framingham. These findings emphasize the need for increased efforts to prevent DM and to aggressively treat and control CVD risk factors among those with DM.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“diabetes-related morbidity and mortality is primarily due to cardiovascular complications [17,18,19].”
From Recent Experimental Studies of Maternal Obesity, Diabetes during Pregnancy and the Developmental Origins of Cardiovascular Disease (2022) · cites this paper as [19]
Citations
Cites
Iakovou, I. P. (2005) · JAMA · doi:10.1001/jama.293.17.2126 · Cited by 3,136
Overweight and obesity in the United States: prevalence and trends, 1960–1994
Flegal, K., Carroll, M., Kuczmarski, R., & Johnson, C. (1998) · International Journal of Obesity · doi:10.1038/sj.ijo.0800541 · Cited by 3,045
The Continuing Epidemics of Obesity and Diabetes in the United States
Mokdad, A. H. (2001) · JAMA · doi:10.1001/jama.286.10.1195 · Cited by 2,730
Harris, M. I., Flegal, K. M., Cowie, C. C., Eberhardt, M. S., Goldstein, D. E., Little, R. R., Wiedmeyer, H.-M., & Byrd-Holt, D. D. (1998) · Diabetes Care · doi:10.2337/diacare.21.4.518 · Cited by 2,703
Increasing Prevalence of Overweight Among US Adults
Kuczmarski, R. J. (1994) · JAMA · doi:10.1001/jama.272.3.205 · Cited by 2,542
Pyörälä, K., Pedersen, T. R., Kjekshus, J., Faergeman, O., Olsson, A. G., Thorgeirsson, G., & The Scandinavian Simvastatin Survival Study (4S) Group (1997) · Diabetes Care · doi:10.2337/diacare.20.4.614 · Cited by 1,623
Comparison of coronary bypass surgery with angioplasty in patients with multivessel disease.
Bourassa, M., Frye, R., King, S., Detre, K., Alderman, E., Andrews, K., & Sopko, G. (1996) · New England Journal of Medicine · doi:10.1056/nejm199607253350401 · Cited by 1,489
Poor Control of Risk Factors for Vascular Disease Among Adults With Previously Diagnosed Diabetes
Saydah, S. H. (2004) · JAMA · doi:10.1001/jama.291.3.335 · Cited by 1,357
Diabetes trends in the U.S.: 1990-1998.
Mokdad, A. H., Ford, E. S., Bowman, B. A., Nelson, D. E., Engelgau, M. M., Vinicor, F., & Marks, J. S. (2000) · Diabetes Care · doi:10.2337/diacare.23.9.1278 · Cited by 1,042
Goldberg, R. B., Mellies, M. J., Sacks, F. M., Moyé, L. A., Howard, B. V., Howard, W. J., Davis, B. R., Cole, T. G., Pfeffer, M. A., & Braunwald, E. (1998) · Circulation · doi:10.1161/01.cir.98.23.2513 · Cited by 986
Flagged first, then by citations
1 of the 38 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 201–300 of 653
Mindfulness and eating behavior in adolescent girls at risk for type 2 diabetes
Pivarunas, B., Kelly, N. R., Pickworth, C. K., Cassidy, O., Radin, R. M., Shank, L. M., Vannucci, A., Courville, A. B., Chen, K. Y., Tanofsky‐Kraff, M., et al. (2015) · International Journal of Eating Disorders · doi:10.1002/eat.22435 · Cited by 37
Lee, H., Lim, T. S., Kim, S. U., & Kim, H. C. (2022) · Hepatology International · doi:10.1007/s12072-022-10407-7 · Cited by 37
Li, X., Sun, C., Zhang, J., Hu, L., Yu, Z., Zhang, X., Wang, Z., Chen, J., Wu, M., & Liu, L. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1122969 · Cited by 39
Insulin Induces Production of New Elastin in Cultures of Human Aortic Smooth Muscle Cells
Shi, J., Wang, A., Sen, S. R., Wang, Y., Kim, H. J., Mitts, T. F., & Hinek, A. (2012) · American Journal Of Pathology · doi:10.1016/j.ajpath.2011.10.022 · Cited by 35
Zhang, M., Sun, D., Li, S., Pan, X., Zhang, X., Zhu, D., Li, C., Zhang, R., Gao, E., & Wang, H. (2015) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.12369 · Cited by 36
Role for Combination Therapy in Diabetic Dyslipidemia
Warraich, H. J., Wong, N. D., & Rana, J. S. (2015) · Current Cardiology Reports · doi:10.1007/s11886-015-0589-5 · Cited by 36
Lin, J. J., Reilly, M. P., Terembula, K., & Wilson, F. P. (2014) · PLoS ONE · doi:10.1371/journal.pone.0114397 · Cited by 36
Fox, C., & Muntner, P. (2008) · Diabetes Care · doi:10.2337/dc07-2348 · Cited by 37
Self-citationChadalavada, S., Jensen, M. T., Aung, N., Cooper, J. A., Lekadir, K., Munroe, P. B., & Petersen, S. E. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.658726 · Cited by 35
Kereliuk, S. M., & Dolinsky, V. W. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23084467 · Cited by 34
Hsu, P., Sung, S., Cheng, H., Shin, S.-J., Lin, K., Chong, K., Yen, F., Yu, B.-H., Huang, C.-T., & Hsu, C.-C. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-00040 · Cited by 35
Prevention of myocardial fibrosis by N-acetyl-seryl-aspartyl-lysyl-proline in diabetic rats
Castoldi, G., Gioia, C. R. T. D., Bombardi, C., Perego, C., Perego, L., Mancini, M., Leopizzi, M., Corradi, B., Perlini, S., Zerbini, G., et al. (2009) · Clinical Science · doi:10.1042/cs20090234 · Cited by 33
The Role of Comorbidities in Cardioprotection
Sack, M. N., & Murphy, E. (2011) · Journal of Cardiovascular Pharmacology and Therapeutics · doi:10.1177/1074248411408313 · Cited by 33
Rajan, S., McNeely, M. J., Hammond, M. C., Goldstein, B., & Weaver, F. M. (2010) · American Journal of Physical Medicine & Rehabilitation · doi:10.1097/phm.0b013e3181d896b9 · Cited by 33
Hoenig, M. R. (2008) · Vascular Health and Risk Management · doi:10.2147/vhrm.2008.04.01.143 · Cited by 33
Cardiovascular Disease and Modifiable Cardiometabolic Risk Factors
Cannon, C. P. (2008) · Clinical cornerstone · doi:10.1016/s1098-3597(09)62037-8 · Cited by 35
Jones, P. H. (2008) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2008.09.074 · Cited by 32
Improving diabetes patient outcomes: Framing research into the chronic care model
Dancer, S., & Courtney, M. (2010) · Journal of the American Academy of Nurse Practitioners · doi:10.1111/j.1745-7599.2010.00559.x · Cited by 36
Koivula, R. W., Tornberg, Å. B., & Franks, P. W. (2013) · Current Diabetes Reports · doi:10.1007/s11892-013-0373-0 · Cited by 31
Diabetes and Cardiovascular Disease: The Potential Benefit of Incretin-Based Therapies
Addison, D., & Aguilar, D. A. (2010) · Current Atherosclerosis Reports · doi:10.1007/s11883-010-0153-0 · Cited by 32
Ducray, P. S., D’ardhuy, X. L., Jamois, C., & Banken, L. (2010) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2009.259 · Cited by 31
Kataoka, Y., Yasuda, S., Miyamoto, Y., Sase, K., Kosuge, M., Kimura, K., Yoshimasa, Y., Miyazaki, S., & on behalf of the DIANA study investigators (2012) · Circulation Journal · doi:10.1253/circj.cj-11-1011 · Cited by 31
Chiu, W.-L., Boyle, J. A., Vincent, A. J., Teede, H. J., & Moran, L. (2016) · Neuroendocrinology · doi:10.1159/000455233 · Cited by 31
The Effect of DPP-4 Inhibitors on Metabolic Parameters in Patients with Type 2 Diabetes
Choe, E. Y., Cho, Y., Choi, Y., Yun, Y., Wang, H. J., Kwon, O., Lee, B., Ahn, C. W., Soo, B., Lee, H. C., et al. (2014) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2014.38.3.211 · Cited by 32
Kataoka, Y., Shao, M., Wolski, K., Uno, K., Puri, R., Tuzcu, E. M., Nissen, S. E., & Nicholls, S. J. (2012) · European Journal of Preventive Cardiology · doi:10.1177/2047487312437931 · Cited by 30
Haxha, S., Halili, A., Malmborg, M. W., Pedersen‐Bjergaard, U., Philbert, B. T., Lindhardt, T. B., Højberg, S., Schjerning, A.-M., Ruwald, M. H., Gislason, G., et al. (2022) · European Heart Journal · doi:10.1093/eurheartj/ehac662 · Cited by 31
Fujihara, K., Sugawara, A., Heianza, Y., Sairenchi, T., Irie, F., Iso, H., Doi, M., Shimano, H., Watanabe, H., Sone, H., et al. (2014) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.22913 · Cited by 30
Chiu, S., Chao, C.-Y., Chiang, E. I., Syu, J., Rodriguez, R. L., & Tang, F. (2017) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2017.01.009 · Cited by 29
Moore, M. P., Cunningham, R. P., Kelty, T. J., Boccardi, L., Nguyen, N., Booth, F. W., & Rector, R. S. (2019) · Applied Physiology, Nutrition, and Metabolism · doi:10.1139/apnm-2019-0042 · Cited by 29
Millar, C. L., Costa, E., Jacques, P. F., Dufour, A. B., Kiel, D. P., Hannan, M. T., & Sahni, S. (2022) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/nqac130 · Cited by 32
DNAzymes and cardiovascular disease
Benson, V. L., Khachigian, L. M., & Lowe, H. C. (2008) · British Journal of Pharmacology · doi:10.1038/bjp.2008.145 · Cited by 29
Type 2 diabetes mellitus is associated with multiple cardiometabolic risk factors
Gerich, J. E. (2007) · Clinical cornerstone · doi:10.1016/s1098-3597(07)80028-7 · Cited by 29
Diabetes Surgery: A New Approach to an Old Disease
Rubino, F., Moo, T.-A. S., Rosen, D. J., Dakin, G. F., & Pomp, A. (2009) · Diabetes Care · doi:10.2337/dc09-s341 · Cited by 29
Myocardial Fatty Acid Metabolism and Lipotoxicity in the Setting of Insulin Resistance
Kok, B. P., & Brindley, D. N. (2012) · Heart Failure Clinics · doi:10.1016/j.hfc.2012.06.008 · Cited by 29
Past and current perspective on new therapeutic targets for Type-II diabetes
Patil, P. D., Mahajan, U. B., Patil, K. R., Chaudhari, S. T., Patil, C. R., Agrawal, Y. O., Ojha, S. K., & Goyal, S. N. (2017) · Drug Design Development and Therapy · doi:10.2147/dddt.s133453 · Cited by 29
Review of the veteran affairs diabetes trial: Lessons learned
Tran, K., & Reaven, P. D. (2020) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-020-09558-5 · Cited by 27
Cardioprotective effects of incretin during ischaemia-reperfusion
Chinda, K., Chattipakorn, S. C., & Chattipakorn, N. (2012) · Diabetes and Vascular Disease Research · doi:10.1177/1479164112440816 · Cited by 28
Echouffo-Tcheugui, J. B., & Kengne, A. P. (2013) · Diabetes & Metabolism · doi:10.1016/j.diabet.2013.07.002 · Cited by 28
Schmittdiel, J. A., DESAI, J. R., Schroeder, E. B., Paolino, A. R., Nichols, G. A., Lawrence, J. M., O’Connor, P. J., Ohnsorg, K. A., Newton, K. M., & Steiner, J. F. (2015) · Healthcare · doi:10.1016/j.hjdsi.2015.02.005 · Cited by 28
Mitochondria as Potential Targets in Antidiabetic Therapy
Moreira, P. I., & Oliveira, C. R. (2011) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-17214-4_14 · Cited by 27
Cho, K. I., Shin, E., Ann, S. H., Garg, S., Her, A., Kim, J., Han, J., & Jeong, M. H. (2016) · Journal of Epidemiology & Community Health · doi:10.1136/jech-2015-207023 · Cited by 27
Huang, K., Wang, J., Zhou, Y., Wu, S., Tao, L., Peng, Y., Que, J., Xue, Y., & Ji, K. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00516 · Cited by 27
Yao, R., Cao, Y., Wang, C., Xu, L. L., Zhang, X., Deng, Y., Li, F., & Wang, S. (2021) · BMC Complementary Medicine and Therapies · doi:10.1186/s12906-021-03218-0 · Cited by 27
Diabetes and Familial Hypercholesterolemia: Interplay between Lipid and Glucose Metabolism
González-Lleó, A. M., Sánchez-Hernández, R. M., Boronat, M., & Wägner, A. M. (2022) · Nutrients · doi:10.3390/nu14071503 · Cited by 31
Galectin-3 Mediates Vascular Dysfunction in Obesity by Regulating NADPH Oxidase 1
Padgett, C. A., Batori, R. K., Speese, A. C., Rosewater, C. L., Bush, W. B., Derella, C. C., Haigh, S. B., Sellers, H. G., Corley, Z. L., West, M. A., et al. (2023) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.123.319476 · Cited by 28
Leroux, C., Gingras, V., Desjardins, K., Brazeau, A., Ott-Braschi, S., Strychar, I. M., & RABASA-LHORET, R. P. R. (2015) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2015.01.004 · Cited by 27
Spermine ameliorates ischemia/reperfusion injury in cardiomyocytes via regulation of autophagy.
Duan, Q., Yang, W., Jiang, D., Tao, K., Dong, A., & Cheng, H. (2016) · PubMed Central · Cited by 27
Cardiovascular benefits of combined interval training and post-exercise nutrition in type 2 diabetes
François, M. E., Pistawka, K. J., Halperin, F. A., & Little, J. P. (2017) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2017.10.002 · Cited by 27
Melman, A., Zotova, E. G., Kim, M., Arezzo, J. C., Davies, K. P., DiSanto, M. E., & Tar, M. (2009) · British Journal of Urology · doi:10.1111/j.1464-410x.2009.08573.x · Cited by 27
Increasing Cardiovascular Disease Burden Due to Diabetes Mellitus: The Framingham Heart Study
Gersh, B. J. (2008) · Yearbook of Cardiology · doi:10.1016/s0145-4145(08)04012-4 · Cited by 27
Abdominal Aortic Calcification Among Individuals With and Without Diabetes: The Jackson Heart Study
Echouffo-Tcheugui, J. B., Allison, M., Kalyani, R. R., Sims, M., Bertoni, A. G., & Golden, S. H. (2017) · Diabetes Care · doi:10.2337/dc17-0720 · Cited by 26
Toh, M. P. H. S., Wu, C. X., & Leong, H. (2011) · Journal of Endocrinology and Metabolism · doi:10.4021/jem.v1i1.20 · Cited by 26
Diabetic kidney disease: a role for advanced glycation end-product receptor 1 (AGE-R1)?
Zhuang, A., & Forbes, J. M. (2016) · Glycoconjugate Journal · doi:10.1007/s10719-016-9693-z · Cited by 27
Coenzyme Q10 protects against acute consequences of experimental myocardial infarction in rats.
Eleawa, S. M., Alkhateeb, M. A., Ghosh, S., Al-Hashem, F. H., Shatoor, A. S., Alhejaily, A., & Khalil, M. A. (2015) · Europe PMC (PubMed Central) · Cited by 25
Biological mechanisms of stroke prevention by physical activity in type 2 diabetes
Agosti, V., Graziano, S., Artiaco, L., & Sorrentino, G. (2009) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.2008.01080.x · Cited by 25
Gilmer, T., O’Connor, P. J., Schiff, J. S., Taylor, G., Vazquez‐Benitez, G., Garrett, J. E., Vue‐Her, H., Rinn, S., Anderson, J., & DESAI, J. R. (2018) · Health Services Research · doi:10.1111/1475-6773.12973 · Cited by 29
Chen, H., Jia, Y., & Guo, Q. (2020) · Studies in natural products chemistry · doi:10.1016/b978-0-12-819483-6.00006-0 · Cited by 25
Omari, M. A., Khader, Y. S., Dauod, A. S., Al‐Akour, N., Khassawneh, A., Al-Ashker, E., & Al-shdifat, A. (2009) · Primary care diabetes · doi:10.1016/j.pcd.2009.08.004 · Cited by 24
Ryanodine Receptor: A New Therapeutic Target to Control Diabetic Cardiomyopathy
Turan, B., & Vassort, G. (2010) · Antioxidants and Redox Signaling · doi:10.1089/ars.2010.3725 · Cited by 27
Myocardial dysfunction and cardiovascular disease in type 2 diabetes
Ofstad, A. P. (2016) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.3109/00365513.2016.1155230 · Cited by 25
Multidisciplinary Approach to Management and Care of Patients with Type 2 Diabetes Mellitus
Bain, S., Cummings, M. H., & McKay, G. A. (2019) · EMJ Diabetes · doi:10.33590/emjdiabet/10314374 · Cited by 22
Li, Q., Li, P., Xu, Z., Lu, Z., Yang, C. H., & Ning, J. (2024) · Cardiovascular Diabetology · doi:10.1186/s12933-024-02318-8 · Cited by 24
Atherosclerotic Cardiovascular Disease in Older Adults with Diabetes Mellitus
Barzilay, J. I., Mukamal, K. J., & Kizer, J. R. (2014) · Clinics in Geriatric Medicine · doi:10.1016/j.cger.2014.09.001 · Cited by 24
Challenges to Healthy Eating Practices
Lee, L. T., Willig, A. L., Agne, A. A., Locher, J. L., & Cherrington, A. (2016) · The Science of Diabetes Self-Management and Care · doi:10.1177/0145721716640904 · Cited by 27
Neergaard‐Petersen, S., Hvas, A., Grove, E. L., Larsen, S. B., Gregersen, S., & Kristensen, S. D. (2015) · PLoS ONE · doi:10.1371/journal.pone.0132629 · Cited by 24
Periodontal Diseases and Diabetes Mellitus: A Systematic Review
Alwithanani, N. A. (2023) · Journal of Pharmacy And Bioallied Sciences · doi:10.4103/jpbs.jpbs_515_22 · Cited by 23
On the importance of global cardiovascular risk assessment in people with type 2 diabetes
Echouffo-Tcheugui, J. B., & Kengne, A. P. (2013) · Primary care diabetes · doi:10.1016/j.pcd.2013.03.002 · Cited by 21
Guo, M. L., Li, R., Yang, L., Zhu, Q., Han, M., Chen, Z., Ruan, F., Yuan, Y., Liu, Z., Huang, B., et al. (2021) · Annals of Translational Medicine · doi:10.21037/atm-20-2337 · Cited by 23
Zhang, Q., Rajagopalan, S. P., Marrett, E., Davies, M. J., Radican, L., & Engel, S. S. (2011) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2011.01498.x · Cited by 22
Samouillan, V., Dandurand, J., Nasarre, L., Badimón, L., Colette Lacabanne, A., & Llorente‐Cortés, V. (2012) · Biophysical Journal · doi:10.1016/j.bpj.2012.06.034 · Cited by 23
Scholtes, V. P. W., Peeters, W., van Lammeren, G. W., Howard, D. P. J., de Vries, J. P. P. M., de Borst, G. J., Redgrave, J. N. E., Kemperman, H., Schalkwijk, C. G., den Ruijter, H. M., et al. (2014) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2014.05.941 · Cited by 23
Gao, L., Bai, L., Shi, M., Ni, J., Lu, H., Wu, Y., Tu, J., Ning, X., Wang, J., & Li, Y. (2017) · Journal of Diabetes Investigation · doi:10.1111/jdi.12639 · Cited by 22
MiR-133a Mimic Alleviates T1DM-Induced Systolic Dysfunction in Akita: An MRI-Based Study
Nandi, S. S., Shahshahan, H. R., Shang, Q., Kutty, S., Boska, M. D., & Mishra, P. K. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.01275 · Cited by 23
He, X., Yao, M., Zhu, M., Liang, D.-L., Guo, W., Yang, Y., Zhao, R., Ren, T., Ao, X., Wang, W., et al. (2018) · Stem Cell Research & Therapy · doi:10.1186/s13287-018-1057-0 · Cited by 23
Canfield, S. G., Žaja, I., Godshaw, B. M., Twaroski, D. M., Bai, X., & Bosnjak, Z. J. (2016) · Anesthesia & Analgesia · doi:10.1213/ane.0000000000001254 · Cited by 23
Kan, W., Kuo, S., Chien, T., Lin, J.-C. J., Yeh, Y.-T., Chou, W., & Chou, P. (2020) · JMIR Medical Informatics · doi:10.2196/11627 · Cited by 21
Nagarathna, R., Kumar, S., Anand, A., Acharya, I. N., Singh, A., Patil, S. S., Latha, R. H., Datey, P., & Nagendra, H. R. (2021) · Medicines · doi:10.3390/medicines8070037 · Cited by 25
Tamaki, N., Wakabayashi, S., Kimura, T., Yasui, Y., Tsuchiya, K., Nakanishi, H., Huang, D. Q., Umemura, T., Kurosaki, M., & Izumi, N. (2024) · Hepatology Research · doi:10.1111/hepr.14025 · Cited by 22
Ariyaratne, T. V., Ademi, Z., Yap, C., Billah, B., Rosenfeldt, F., Yan, B. P., & Reid, C. M. (2014) · International Journal of Cardiology · doi:10.1016/j.ijcard.2014.06.072 · Cited by 22
Zhao, Y., Li, N., Zhu, L., Zhang, D., Chen, L., Yao, Z., & Niu, W. (2017) · Metabolism · doi:10.1016/j.metabol.2017.12.008 · Cited by 23
miR-1231 exacerbates arrhythmia by targeting calciumchannel gene CACNA2D2 in myocardial infarction.
Zhang, J., Wu, L., Li, Z., & Fu, G. (2017) · PubMed Central · Cited by 22
Sun, G., Ma, M., Ye, N., Wang, J., Chen, Y., Dai, D., & Sun, Y. (2016) · Journal of Diabetes Investigation · doi:10.1111/jdi.12476 · Cited by 22
Yang, W., Duan, Q., Zhu, X., Tao, K., & Dong, A. (2019) · BioMed Research International · doi:10.1155/2019/9537382 · Cited by 22
Qin, Y., Yan, G., Qiao, Y., Wang, D., Luo, E., Hou, J., & Tang, C. (2020) · BMC Cardiovascular Disorders · doi:10.1186/s12872-020-01394-4 · Cited by 21
Overview of Risk Factors for Cardiovascular Disease
Rillamas‐Sun, E., Beasley, J. M., Hyde, E. T., & LaCroix, A. Z. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-384978-6.00062-5 · Cited by 22
Alexander, N., Matsushita, K., Sang, Y., Ballew, S. H., Mahmoodi, B. K., Astor, B. C., & Coresh, J. (2015) · American Journal of Nephrology · doi:10.1159/000433450 · Cited by 19
Roles of microRNAs in pressure overload- and ischemia-related myocardial remodeling
Zhou, S., Liu, Y., Prater, K., Zheng, Y., & Cai, L. (2013) · Life Sciences · doi:10.1016/j.lfs.2013.08.023 · Cited by 22
Pipino, C., Shah, H., Prudente, S., Pietro, N. D., Zeng, L., Park, K., Trischitta, V., Pennathur, S., Pandolfi, A., & Doria, A. (2020) · Diabetes · doi:10.2337/db20-0475 · Cited by 21
Bozorgmanesh, M., Hadaegh, F., Sheikholeslami, F. H., & Azizi, F. (2012) · PubMed · doi:10.3275/7728 · Cited by 21
Management of hypertension in patients with diabetes: the place of angiotensin‐II receptor blockers
Kalaitzidis, R., & Bakris, G. L. (2009) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2009.01052.x · Cited by 21
Nemoto, M., Tajima, N., & Kawamori, R. (2010) · Acta Diabetologica · doi:10.1007/s00592-010-0206-4 · Cited by 21
Lin, J. J., Khetarpal, S. A., Terembula, K., Reilly, M. P., & Wilson, F. P. (2015) · BMC Nephrology · doi:10.1186/s12882-015-0122-5 · Cited by 22
Use of SGLT-2 inhibitors in the treatment of type 2 diabetes mellitus
Santos, L. L., de Lima, F. J. C., de Sousa‐Rodrigues, C. F., & Barbosa, F. T. (2017) · Revista da Associação Médica Brasileira · doi:10.1590/1806-9282.63.07.636 · Cited by 22
Anholm, C., Kumarathurai, P., Klit, M. S., Kristiansen, O. P., Nielsen, O. W., Ladelund, S., Madsbad, S., Sajadieh, A., & Haugaard, S. B. (2014) · BMJ Open · doi:10.1136/bmjopen-2014-005942 · Cited by 18
Yatsuya, H., Yamagishi, K., & Iso, H. (2011) · The EPMA Journal · doi:10.1007/s13167-011-0071-4 · Cited by 19
Chao, C., Lee, S., Wang, J., Chien, K., & Hung, K. (2021) · Cardiovascular Diabetology · doi:10.1186/s12933-021-01279-6 · Cited by 19
Jensen, M. T., Søgaard, P., Andersen, H. U., Gustafsson, I., Bech, J. W., Hansen, T. F., Theilade, S., Almdal, T., Rossing, P. R., & Jensen, J. S. (2016) · Diabetes and Vascular Disease Research · doi:10.1177/1479164116637310 · Cited by 19
Effect of liraglutide on dietary lipid‐induced insulin resistance in humans
Koška, J., Lopez, L. K., D’Souza, K. M., Osredkar, T., Deer, J., Kurtz, J., Salbe, A. D., Harman, S. M., & Reaven, P. D. (2017) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13037 · Cited by 21
Factors Associated with Poor Hemoglobin A1c Control in Patients with Type 2 Diabetes
Alqudah, S., Jarab, A. S., Alefishat, E. A., Mayyas, F., Khdour, M. R., & Pinto, S. (2018) · Current Diabetes Reviews · doi:10.2174/1573399814666180510144858 · Cited by 19
Vurusaner, B., Thevkar-Nages, P., Kaur, R., Giannarelli, C., Garabedian, M. J., & Fisher, E. A. A. (2022) · Scientific Reports · doi:10.1038/s41598-022-15349-6 · Cited by 18
Metadata
- Authors
- Fox, C. S., Coady, S., Sorlie, P. D., D’Agostino, R. B., Pencina, M. J., Vasan, R. S., Meigs, J. B., Levy, D., & Savage, P. J.
- Affiliations
- Boston University (US)
- ORCID
- Venue
- Circulation
- Published
- 2007-03-27
- Volume
- 115
- Issue
- 12
- Pages
- 1544-1550
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2055416829
- Cited by
- 656
- References
- 38
- Citations by year
- 2026: 11 · 2025: 15 · 2024: 20 · 2023: 19 · 2022: 35 · 2021: 25 · 2020: 27 · 2019: 23 · 2018: 32 · 2017: 38 · 2016: 42 · 2015: 46 · 2014: 49 · 2013: 35 · 2012: 52
- FWCI
- 33.94
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Circulation (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (n01hc25195-41-0-1)
- U.S. Public Health Service (5K24H004334)
- National Heart, Lung, and Blood Institute (N01‐HC25195)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Epidemiology › Healthcare Systems and Public Health
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Risk Factors
- Keywords
- diabetes mellitus, cardiovascular disease, population attributable risk, cardiovascular risk factors, temporal trends, Framingham Heart Study, middle-aged adults, diabetes prevention, cardiovascular risk management
- MeSH terms
- Blood Glucose, Cardiovascular Diseases, Diabetes Mellitus, Female, Humans, Hypertension, Male, Middle Aged, Obesity, Risk, Risk Factors, Smoking, United States, Cohort Studies, Incidence, Proportional Hazards Models, Diabetes Complications
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review